(Q47878727)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857200%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

title

By inhibiting PFKFB3, aspirin overcomes sorafenib resistance in hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857200%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857200%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Chuanyong Guo

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857200%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

8

Qiang Yu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857200%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

16

Yingqun Zhou

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857200%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

author name string

Weiqi Dai

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857200%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Wenhui Mo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857200%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Jingjing Li

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857200%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Jiao Feng

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857200%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Liwei Wu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857200%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Tong Liu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857200%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Shizan Xu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857200%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Wenwen Wang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857200%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Xiya Lu

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857200%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Qinghui Zhang

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857200%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Kan Chen

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857200%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Yujing Xia

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857200%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Jie Lu

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857200%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Xiaoming Fan

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857200%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Ling Xu

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857200%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

language of work or name

English

0 references

publication date

14 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857200%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

28 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857200%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

volume

141

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857200%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857200%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

page(s)

2571-2584

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857200%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

cites work

Cancer Statistics, 2017.

1 reference

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Discovery and development of sorafenib: a multikinase inhibitor for treating cancer.

21 January 2018

1 reference

Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma.

21 January 2018

1 reference

Sunitinib versus sorafenib in advanced hepatocellular cancer: results of a randomized phase III trial

21 January 2018

1 reference

Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL study

21 January 2018

1 reference

Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial

21 January 2018

1 reference

PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation

21 January 2018

1 reference

Otto Warburg's contributions to current concepts of cancer metabolism

21 January 2018

1 reference

Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism

21 January 2018

1 reference

Modulation of glycolysis and lipogenesis by novel PI3K selective molecule represses tumor angiogenesis and decreases colorectal cancer growth.

21 January 2018

1 reference

Carboxyamidotriazole inhibits oxidative phosphorylation in cancer cells and exerts synergistic anti-cancer effect with glycolysis inhibition

21 January 2018

1 reference

Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma

21 January 2018

1 reference

Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma

21 January 2018

1 reference

Blocking preferential glucose uptake sensitizes liver tumor-initiating cells to glucose restriction and sorafenib treatment.

21 January 2018

1 reference

Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer

21 January 2018

1 reference

Anti-inflammatory Agents: Present and Future

21 January 2018

1 reference

Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials

21 January 2018

1 reference

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.

21 January 2018

1 reference

Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma

21 January 2018

1 reference

Aspirin use and survival after diagnosis of colorectal cancer

21 January 2018

1 reference

The ancient drug salicylate directly activates AMP-activated protein kinase

21 January 2018

1 reference

The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer

21 January 2018

1 reference

Acetylsalicylic acid and salicylic acid decrease tumor cell viability and glucose metabolism modulating 6-phosphofructo-1-kinase structure and activity

21 January 2018

1 reference

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

21 January 2018

1 reference

By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice.

21 January 2018

1 reference

In vitro and in vivo study of epigallocatechin-3-gallate-induced apoptosis in aerobic glycolytic hepatocellular carcinoma cells involving inhibition of phosphofructokinase activity.

21 January 2018

1 reference

QSG-7701 human hepatocytes form polarized acini in three-dimensional culture

21 January 2018

1 reference

Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells

21 January 2018

1 reference

Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis.

21 January 2018

1 reference

Resveratrol attenuates vascular endothelial inflammation by inducing autophagy through the cAMP signaling pathway

21 January 2018

1 reference

Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD.

21 January 2018

1 reference

21 January 2018

Mitochondria and Cancer

1 reference

Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics.

21 January 2018

1 reference

Caspase cleavage of cytochrome c1 disrupts mitochondrial function and enhances cytochrome c release

21 January 2018

1 reference

Phosphorylation of Bad at Thr-201 by JNK1 promotes glycolysis through activation of phosphofructokinase-1.

21 January 2018

1 reference

21 January 2018

Hepatocellular carcinoma

1 reference

Methylation-regulated miR-124-1 suppresses tumorigenesis in hepatocellular carcinoma by targeting CASC3.

21 January 2018

1 reference

Genistein inhibits hepatocellular carcinoma cell migration by reversing the epithelial-mesenchymal transition: partial mediation by the transcription factor NFAT1.

21 January 2018

1 reference

Astaxanthin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cells via Inhibition of Nf-Κb P65 and Wnt/Β-Catenin in Vitro.

21 January 2018

1 reference

Focal gains of VEGFA: candidate predictors of sorafenib response in hepatocellular carcinoma.

21 January 2018

1 reference

Nitric oxide-donating aspirin inhibits the growth of pancreatic cancer cells through redox-dependent signaling

21 January 2018

1 reference

Pharmacoepidemiology of Clinically Relevant Hypothyroidism and Hypertension from Sunitinib and Sorafenib

21 January 2018

1 reference

Economic evaluation of sorafenib in unresectable hepatocellular carcinoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.31022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28857200%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference